Skip to main content
SpringerLink
Log in

Osteoporosemittel

  • Chapter
  • First Online:
Arzneiverordnungs-Report 2019

  • 2859 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Arzneimittelkommission der Deutschen Ärzteschaft (2008) Empfehlungen zur Therapie und Prophylaxe der Osteoporose, 2. Aufl. Arzneiverordnung in der Praxis, Bd. Sonderheft (http://www.akdae.de/35/83_Osteoporose_2008_2Auflage.pdf)

    Google Scholar 

  • Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, Hercz G, Cunningham J, Abu-Alfa AK, Messa P, Coyne DW, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier A, Braun J, McCary LC, Zani VJ, Olson KA, Drueke TB, Goodman WG (2004) Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 350:1516–1525

    Article  CAS  Google Scholar 

  • Bolland MJ, Grey A, Reid IR (2013) Calcium supplements and cardiovascular risk: 5 years on. Ther Adv Drug Saf 4:199–210

    Article  Google Scholar 

  • Bone HG, Hosking D, Devogelaer JP, Tucci JR, Emkey RD, Tonino RP, Rodriguez-Portales JA, Downs RW, Gupta J, Santora AC, Liberman UA, Alendronate Phase III Osteoporosis Treatment Study Group (2004) Ten years’ experience with alendronate for osteoporosis in postmenopausal women. N Engl J Med 350:1189–1199

    Article  CAS  Google Scholar 

  • Brown JE, Coleman RE (2012) Denosumab in patients with cancer-a surgical strike against the osteoclast. Nat Rev Clin Oncol 9:110–118

    Article  CAS  Google Scholar 

  • Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, Delmas P, Zoog HB, Austin M, Wang A, Kutilek S, Adami S, Zanchetta J, Libanati C, Siddhanti S, Christiansen C, FREEDOM Trial (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756–765

    Article  CAS  Google Scholar 

  • Dachverband Osteologie (2014) Prophylaxe, Diagnostik und Therapie der Osteoporose bei Männern ab dem 60. Lebensjahr und bei postmenopausalen Frauen. S3-Leitlinie des Dachverbands der Deutschsprachigen Wissenschaftlichen Osteologischen Gesellschaften e.V. – Kurzfassung und Langfassung. http://www.dv-osteologie.org/dvo_leitlinien/osteoporose-leitlinie-2014

    Google Scholar 

  • Drüeke TB (2007) Lanthanum carbonate as a first-line phosphate binder: the “cons”. Semin Dial 20:329–332

    Article  Google Scholar 

  • Edwards BJ, Sun M, West DP, Guindani M, Lin YH, Lu H, Hu M, Barcenas C, Bird J, Feng C, Saraykar S, Tripathy D, Hortobagyi GN, Gagel R, Murphy WA (2016) Incidence of atypical femur fractures in cancer patients: The MD Anderson Cancer Center Experience. J Bone Miner Res 31:1569–1576

    Article  Google Scholar 

  • Favia G, Pilolli GP, Maiorano E (2009) Histologic and histomorphometric features of bisphosphonate-related osteonecrosis of the jaws: an analysis of 31 cases with confocal laser scanning microscopy. Bone 45:406–413

    Article  CAS  Google Scholar 

  • Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, Women’s Health Initiative Investigators et al (2006) Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 354:669–683

    Article  CAS  Google Scholar 

  • Lamy O (2012) Knochenanabole Therapie mit Teriparatid. Ther Umsch 69:187–191

    Article  Google Scholar 

  • Lyles KW, Colon-Emeric CS, Magaziner JS, Adachi JP, Pieger CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, Lavecchia C, Zhang J, Mesenbrink P, Hodgson PK, Abrams K, Orloff JJ, Horowitz Z, Eriksen EF, Boonen S, HORIZON Recurrent Fracture Trial (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357:1799–1810

    Article  CAS  Google Scholar 

  • Malberti F (2013) Hyperphosphataemia: treatment options. Drugs 73:673–688

    Article  CAS  Google Scholar 

  • Manns B, Klarenbach S, Lee H, Culleton B, Shrive F, Tonelli M (2007) Economic evaluation of sevelamer in patients with end-stage renal disease. Nephrol Dial Transplant 22:2867–2878

    Article  Google Scholar 

  • Navaneethan SD, Palmer SC, Vecchio M, Craig JC, Elder GJ, Strippoli GF (2011) Phosphate binders for preventing and treating bone disease in chronic kidney disease patients. Cochrane Database Syst Rev 2011 Feb 16; (2): CD006023

    Google Scholar 

  • NIH Consensus Conference (1994) Optimal calcium intake. JAMA 272:1942–1948

    Article  Google Scholar 

  • Pazianas M, Compston J, Huang CL (2010) Atrial fibrillation and bisphosphonate therapy. J Bone Miner Res 25:2–10

    Article  CAS  Google Scholar 

  • Rachner TD, Khosla S, Hofbauer LC (2011) Osteoporosis: now and the future. Lancet 377:1276–1287

    Article  CAS  Google Scholar 

  • Rizzoli R, Boonen S, Brandi ML, Burlet N, Delmas P, Reginster JY (2008) The role of calcium and vitamin D in the management of osteoporosis. Bone 42:246–249

    Article  CAS  Google Scholar 

  • Shane E, Burr D, Ebeling PR, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster D, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Koval K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O’Keefe R, Papapoulos S, Sen HT, van der Meulen MC, Weinstein RS, Whyte M, American Society for Bone and Mineral Research (2010) Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 25:2267–2294

    Article  Google Scholar 

  • Straub DA (2007) Calcium supplementation in clinical practice: a review of forms, doses, and indications. Nutr Clin Pract 22:286–296

    Article  Google Scholar 

  • Suki W, Zabaneh R, Cangiano J, Reed J, Fischer D, Garrett L, Ling B, Chasan-Taber S, Dillon M, Blair A, Burke S (2006) A prospective, randomized trial assessing the impact on outcomes of sevelamer in dialysis patients. The DCOR trial. Nephrol Dial Transplant 21(Suppl 4):145–146

    Google Scholar 

  • The EVOLVE Trial Investigators (2012) Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med 367:2482–2494

    Article  Google Scholar 

  • Wade SW, Curtis JR, Yu J, White J, Stolshek BS, Merinar C, Balasubramanian A, Kallich JD, Adams JL, Viswanathan HN (2012) Medication adherence and fracture risk among patients on bisphosphonate therapy in a large United States health plan. Bone 50:870–875

    Article  Google Scholar 

  • Ziegler R (2002) Osteoporose: aktuelle Diagnostik und Therapie. Orthop Prax 38:570–577

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sektion Osteologie an der Medizinischen Klinik (Krehl-Klinik), Abt. Innere Medizin I und Klinische Chemie des Universitätsklinikums Heidelberg, Heidelberg, Deutschland

    Prof. Dr. med. Dr. med. dent. Dr. h.c. Hans Christian Kasperk

  2. Heidelberg, Deutschland

    Prof. Dr. med. h.c. Reinhard Ziegler

Authors
  1. Prof. Dr. med. Dr. med. dent. Dr. h.c. Hans Christian Kasperk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. med. h.c. Reinhard Ziegler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hans Christian Kasperk .

Editor information

Editors and Affiliations

  1. Pharmakologisches Institut, Universität Heidelberg, Heidelberg, Baden-Württemberg, Germany

    Ulrich Schwabe

  2. Köln, Nordrhein-Westfalen, Germany

    Dieter Paffrath

  3. Arzneimittelkommission der deutschen Ärzteschaft (AkdÄ), Berlin, Berlin, Germany

    Wolf-Dieter Ludwig

  4. Wissenschaftliches Institut der AOK, Berlin, Berlin, Germany

    Jürgen Klauber

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kasperk, H.C., Ziegler, R. (2019). Osteoporosemittel. In: Schwabe, U., Paffrath, D., Ludwig, WD., Klauber, J. (eds) Arzneiverordnungs-Report 2019. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-59046-1_39

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-59046-1_39

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-59045-4

  • Online ISBN: 978-3-662-59046-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation